Finance

Lists
Why is RMTI up 7,59%?
Dive Deeper
RMTI:NASDAQ
Rockwell Medical Ord Shs
8,22 USD
+7,59%
(+0,58) 1D
7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMTI...
Open
7,68 USD
High
8,31 USD
Low
7,68 USD
Mkt. cap
33,13 млн
Avg. vol.
22,48 миң
Volume
3,00
52-wk high
12,90 USD
52-wk low
4,88 USD
EPS
-1,37 USD
Beta
1,63
Shares outstanding
4,03 млн
No. of employees
157
Open
7,68 USD
High
8,31 USD
Low
7,68 USD
Mkt. cap
33,13 млн
Avg. vol.
22,48 миң
Volume
3,00
52-wk high
12,90 USD
52-wk low
4,88 USD
EPS
-1,37 USD
Beta
1,63
Shares outstanding
4,03 млн
No. of employees
157
News stories
From web sources and news partners
Profile
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease. The company's primary customers are dialysis providers. Wikipedia
About Rockwell Medical Ord Shs
CEO-
Employees157
Founded1996
HeadquartersУиксом, Мичиган, Америка Кошмо Штаттары
SectorMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to RMTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RMTI in the last 3 months.
Highest
Current 8,22 USD
20,00 USD (+143,31%)
Average
20,00 USD (+143,31%)
Lowest
20,00 USD (+143,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
20,00 USD
+143,3%
09/11/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
20,00 USD
+143,3%
08/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
15,93 млн
18,35 млн
17,34 млн
17,78 млн
Cost of goods sold
13,66 млн
14,47 млн
14,44 млн
14,54 млн
Cost of revenue
13,66 млн
14,47 млн
14,44 млн
14,54 млн
Research and development expenses
-
-
-
40,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,86 млн
4,28 млн
4,38 млн
4,26 млн
Operating expense
3,86 млн
4,28 млн
4,38 млн
4,30 млн
Total operating expenses
17,51 млн
18,74 млн
18,82 млн
18,84 млн
Operating income
-1,58 млн
-398,00 миң
-1,48 млн
-1,06 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,75 млн
-554,00 миң
-1,60 млн
-1,17 млн
EBT excluding unusual items
-1,81 млн
-640,00 миң
-1,72 млн
-1,30 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,75 млн
-554,00 миң
-1,60 млн
-1,17 млн
Net profit margin
-11,01%
-3,02%
-9,26%
-6,59%
Earnings per share
-
-
-
-
Interest and investment income
55,00 миң
44,00 миң
37,00 миң
40,00 миң
Interest expense
-285,00 миң
-286,00 миң
-282,00 миң
-281,00 миң
Net interest expenses
-230,00 миң
-242,00 миң
-245,00 миң
-241,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,04 млн
148,00 миң
-969,00 миң
-569,00 миң
Gain or loss from assets sale
-1,00 миң
1,00 миң
178,00 миң
-32,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору